In the United States, slightly more than half of all adults with diabetes receive guideline-consistent care. A smaller proportion has adequate cardiovascular risk factor control. Current care of individuals with diabetes and its complications and comorbidities exemplifies many of the challenges facing the U.S. healthcare system. Based on the care costs relative to the outcomes achieved, Americans deserve greater value for our healthcare expenditures.
Acknowledging the convergence of the diabetes epidemic and the passage of the Affordable Care Act (ACA), the Endocrine Society (ES) seized the opportunity to convene a Washington, DC, Summit on September 12, 2014, to explore the law’s impact on patients with diabetes. Summit attendees and speakers included leading diabetes stakeholders, patient advocacy and community-based groups, health plans, research institutions, federal agencies, and policy makers. The agenda featured potential policy solutions as well as challenges and opportunities resulting from ACA implementation. In the following paragraphs, the ES briefly summarizes the proceedings.
Loading ...